Graefes Arch Clin Exp Ophthalmol (2017) 255:1713–1720 DOI 10.1007/s00417-017-3706-x RETINAL DISORDERS Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy? 1 2 1 1 Paolo Milani & Marco Pellegrini & Amedeo Massacesi & Stefania Moschini & 1 3 3 2 Marco Setaccioli & Davide Soranna & Antonella Zambon & Ferdinando Bottoni & Fulvio Bergamini Received: 3 March 2017 /Revised: 15 May 2017 /Accepted: 30 May 2017 /Published online: 30 June 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract and of lesion-adjacent ellipsoid zone at baseline were factors Purpose To evaluate functional prognostic factors and forbetterfinal BCVA (p ≤ 0.05) neuroretinal changes after anti-vascular endothelial growth Conclusion Vision gain might occur despite ellipsoid zone or factor (VEGF) treatment in patients with naïve, recent myopic ELM restoration. Hemorrhage could be considered a negative neovascularization (mCNV), as assessed by spectral-domain prognostic factor, integrity of lesion-adjacent ELM and of optical coherence tomography (SD-OCT). lesion-adjacent ellipsoid zone as positive prognostic factors. Methods Specific changes in tomographic features between Myopic CNV can also resolve completely without fibrosis. baseline and final follow-up were retrospectively evaluated . . by two examiners independently. Imaging was obtained by a Keywords Myopic neovascularization Pathologic myopia . .
Graefe's Archive for Clinical and Experimental Ophthalmology – Springer Journals
Published: Jun 30, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud